The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA from 06th June, 2022 to 17th June, 2022.
At the end of the inspection, the Company has received Form 483 with three (3) observations. The Company shall submit to US FDA within the stipulated timeline, a detailed response to close out all the observations associated with this inspection.
Shares of Alkem Laboratories Limited was last trading in BSE at Rs. 3097.70 as compared to the previous close of Rs. 3042.05. The total number of shares traded during the day was 2103 in over 617 trades.
The stock hit an intraday high of Rs. 3103.20 and intraday low of 3021.15. The net turnover during the day was Rs. 6447939.00.